Sharon M. Watling
Keine laufenden Positionen mehr
Profil
Sharon M.
Watling worked as a Senior Director of Clinical Development at Metabasis Therapeutics, Inc. and as a Vice President of Clinical and Regulatory at Vericel Corp.
She holds a doctorate degree from the University of Michigan.
Ehemalige bekannte Positionen von Sharon M. Watling
| Unternehmen | Position | Ende |
|---|---|---|
Metabasis Therapeutics, Inc.
 Metabasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Metabasis Therapeutics, Inc. engages in discovery, development and commercialization of novel drugs for metabolic diseases using the proprietary technology and the knowledge of processes and pathways within the liver that are useful for liver-selective drug targeting and treatment of metabolic diseases. Metabasis was incorporated in April 1997 and is headquartered in La Jolla, CA. | Technik-/Wissenschafts-/F&E-Leiter | - |
| VERICEL CORPORATION | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Sharon M. Watling
| University of Michigan | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| VERICEL CORPORATION | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Metabasis Therapeutics, Inc.
Metabasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Metabasis Therapeutics, Inc. engages in discovery, development and commercialization of novel drugs for metabolic diseases using the proprietary technology and the knowledge of processes and pathways within the liver that are useful for liver-selective drug targeting and treatment of metabolic diseases. Metabasis was incorporated in April 1997 and is headquartered in La Jolla, CA. | Health Technology |
